Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2026EFSA JournalOpen Access

Safety of oil from Schizochytrium sp. A2 for use in infant and follow‐on formula as a novel food pursuant to regulation (EU) 2015/2283

View Full Paper
Ask AI
Bookmark
Share

Authors

NNNovel Foods and Food Allergens (NDA) EFSA Panel on NutritionDTDominique TurckTBTorsten Bohn

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates the safety of Schizochytrium sp. A2 oil in infant formula, indicating safety concerns remain unresolved.

Key Points

  • To assess the safety of Schizochytrium sp. A2 oil as a novel food for infant and follow-on formulas.
  • Review of safety evidence as per Regulation (EU) 2015/2283
  • Assessment of proposed intake levels of 3 g DHA per day
  • Evaluation of existing toxicological data from other Schizochytrium strains.
  • Safety of Schizochytrium sp. A2 oil cannot be established due to unresolved species identity.
  • Batch analyses show marine biotoxins below limits, but potential for unknown toxins remains.
  • No specific toxicological studies for oil from strain A2 were provided.

Cite This Study

Nutrition et al. (2026) studied this question.

synapsesocial.com/papers/6a06b74ce7dec685947aa47chttps://doi.org/10.2903/j.efsa.2026.10097
View Full Paper
Ask AI
Bookmark
Share